Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Plos One|April 15, 2022
Social determinants of health and HIV Pre-Exposure Prophylaxis (PrEP) interest and use among young Black and Latinx sexual minority menTyler M Andriano, Julia Arnsten, Viraj V Patel
Addictive Behaviors|February 14, 2006
Cigarette smoking and interest in quitting in methadone maintenance patientsShadi Nahvi, Kimber Richter, Xuan Li, et al.
Diagnosis (Berlin, Germany)|March 23, 2019
Development and evaluation of a clinical reasoning curriculum as part of an Internal Medicine Residency ProgramShwetha Iyer, Erin Goss, Casey Browder, et al.
Medical Care|October 28, 2008
Self-report adherence measures in chronic illness: retest reliability and predictive validityAnthony Jerant, Robin DiMatteo, Julia Arnsten, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 17, 2021
The Impact of Coping With Stressful Events on Negative Affect and Cravings Among Smokers With Mood DisordersDanusha Selva Kumar, Shadi Nahvi, Monica Rivera-Mindt, et al.
Journal of General Internal Medicine|July 10, 2023
Individual and Health System Factors for Uptake of Pre-exposure Prophylaxis Among Young Black and Latino Gay MenElí A Andrade, Georgianna Stoukides, Anthony F Santoro, et al.
The American Journal on Addictions|February 15, 2003
Modified directly observed therapy (MDOT) for injection drug users with HIV diseaseElinore F McCance-Katz, Marc N Gourevitch, Julia Arnsten, et al.
AIDS Care|August 5, 2020
Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaineDeepika E Slawek, Julia Arnsten, Nancy Sohler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug usersAmy Knowlton, Julia Arnsten, Lois Eldred, et al.
Addiction Science & Clinical Practice|October 25, 2021
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programsTravis M Scott, Julia Arnsten, James Patrick Olsen, et al.
Pageof 4